$-0.03
(Market cap
$3 Mln
Revenue (TTM)
$6 Mln
P/E Ratio
1.2
P/B Ratio
6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-143.6 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
-1.2
-
Debt to Equity
-48.7
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
3,906,070
10 Years Aggregate
CFO
$-21.95 Mln
EBITDA
$-36.22 Mln
Net Profit
$-51.53 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
INVO BioScience (INVO)
| -46.5 | -16.4 | 3.9 | -41.3 | -78.6 | -65.2 | -42.0 |
|
BSE Sensex*
| -8.8 | 0.6 | 1.8 | -4.4 | 6.0 | 6.6 | 10.8 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|---|---|---|---|---|---|---|---|
|
INVO BioScience (INVO)
| -84.1 | -87.3 | 10.6 | -56.5 | -48.5 | 169.6 | -55.7 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout INVO BioScience (INVO)
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development... to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida. Read more
-
CEO & Director
Mr. Steven M. Shum
-
CEO & Director
Mr. Steven M. Shum
-
Headquarters
Sarasota, FL
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for INVO BioScience (INVO)
What is the current share price of INVO BioScience Inc (INVO) Today?
The share price of INVO BioScience Inc (INVO) is $0.72 (NASDAQ) as of 23-Dec-2024 09:30 EDT. INVO BioScience Inc (INVO) has given a return of -78.55% in the last 3 years.
What is the current PB & PE ratio of INVO BioScience Inc (INVO)?
The P/E ratio of INVO BioScience Inc (INVO) is 1.21 times as on 23-Dec-2024, a 97 discount to its peers’ median range of 44.46 times.
The P/B ratio of INVO BioScience Inc (INVO) is 5.97 times as on 23-Dec-2024, a 55 premium to its peers’ median range of 3.84 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2023 |
-- |
-- |
2022 |
-- |
-- |
2021 |
-- |
-- |
2020 |
-- |
-- |
2019 |
-- |
-- |
What is the 52 Week High and Low of INVO BioScience Inc (INVO)?
The 52-week high and low of INVO BioScience Inc (INVO) are Rs -- and Rs -- as of 30-Aug-2026.
What is the market cap of INVO BioScience Inc (INVO)?
INVO BioScience Inc (INVO) has a market capitalisation of $ 3 Mln as on 23-Dec-2024. As per SEBI classification, it is a Small Cap company.
Should I invest in INVO BioScience Inc (INVO)?
Before investing in INVO BioScience Inc (INVO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.